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Epidermal Langer hans ce lls (LC) are related to certain 
cells of t he monocyte-macrophage lineage and to other 
d e ndritic cells . While epidermal L C a nd macrophages 
b ear receptors for the Fe portion of IgG, other dendritic 
cells do not . However, unlike human dendritic cells from 
p e rip heral blood, LC bear the a n t igen aga inst which the 
o KT6 a ntibody is directed. Wit hin the skin this antibody 
bin d s only to LC or indeterminate cells. Functionally LC 
a nd dendritic cells can present a ntigen to sensitized T 
cells and are capable of stimulating allogenic T cells. 
Since lymphokines are thought to play an important role 
in T - cell activation and since LC are potent stimulators 
of antigen-specific T-cell proliferation, we investigated 
w hetlter LC could produce interleukin-1 (IL- l) . Our 
ini t i a l s tudies revealed t hat whole epidermal cell sus-
pens ions comprised of LC, keratinocy tes, and melano-
c y t e s produce a factor that is simila r to m acrophage -
derived IL-l. We termed this factor epiderm~! cell -de -
rived thy mocyte-activating factor (ETAF ). Usmg a pan-
n i n g t echnique w e obta ined a highly enriched (up to 
9 7 % ) population of LC which constitutive ly produced 
s i g nificant IL- l-like activity . U~ing a n a ntibody agai~st 
t h e monocy te-derived leukocytic pyrogen (L P) which 
h a s b e en shown to inhibit IL- l a ctivity , we were able to 
inhibit IL- l activity from LC-enriched cultures. The 
results of this study indicate that within the epide rmis 
t here are at leas t two cell populations, k e ratinocy tes and 
LC, t hat can constitutively secrete pote ntially important 
soluble immunostimulatory factors . 
Epid erma l La ngerha ns cell s (~C~ are dendri_tic_ ce ll s wit h in 
t h e ep idermis t hought to p lay a Sigm fican t role Ill 11nmu~o logic 
reacti o ns t ha t occur in the skin . LC a re related to certam cel!s 
of t h e monocyte- macrop hage lineage and to ot~1er dend_n t ic 
cells [1-5]. H uma n LC, un like human dendn t ic ce lls from 
perip h era l blood, bea r t he an t ige n _again ~t which t he O~T6 
a n t ibody is directed [.5,6). While this a nt ibody reacts agam st 
t h e a n t ige n found on cort ical t hymocytes, wit hin t he epiderm is 
it b inds on ly to LC or indeterminate cells [6,7). Functionally 
LC a nd dendri t ic cells can presen t an t igen to sensitized T cells 
a n d are capable of stimulating a llogeneic T ce lls [1 ,5]. Recent 
eviden ce indicates t hat stimulation of an tige n-specific T -cell 
p r o life ration by certa in cell type~ requires t he deli_very of t_wo 
s ignal s: presen tation of antJgei: In conJU~Ct!On with I -! eglOn 
p r o du c t s (signa l 1) a nd productiOn of a n~Ige n n onspec ~fi c a m-
p li f ication factors, presumably inter leukm-1 (IL-l) (signal 2) 
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[8). S ince LC a re potent stimulato rs of a nt igen -specific T-cell 
proli ferat ion , we investigated whether LC could produce IL-L 
Our in it ia l studies revealed t hat whole epiderma l cell suspen-
s ions comprised of LC, keratinocytes, and mela nocytes produce 
a factor t hat is simila r to macrophage-deri ved IL-l [9], termed 
epiderma l cell -derived t hymocyte-activating factor (ETAF). 
Recent ly, panni ng tec hniques fo r enriching human LC have 
been developed [10,11 ], based on t he method of Wysocki and 
Sato [12). Using such tec hniques we were able to achieve a 
highly enriched (up to 97%) popu lation of LC. Using t he highly 
enr iched LC popu lation , we cou ld d irectly investigate whether 
LC produce IL-l. S ignifican t constit ut ive production of IL -l -
like activity was found in t he LC-enriched as we ll as t he LC-
depJeted population . Using an a nt ibody against t he monocyte-
derived leukocytic pyrogen (LP), which has been shown to 
inhibi t IL-l activity [13], we were able to inhi bit IL -l or ETAF 
activity from LC-enriched a nd -depleted cell cul tures . T he 
resul ts of t his study indicate t hat within t he epidermis the re 
a re at least two ce ll populations, keratinocytes and LC, t hat 
can constit ut ively secrete poten t ia lly important so luble immu-
nost.imulatory facto rs. This is t he first report t hat a specia lized 
huma n dendri t ic ce ll (LC) can produce IL-l. 
MATERIALS AND M ETHODS 
Preparation of Cell Suspension 
Single ce ll suspensions of normal human sk in were obtained at 
. urgery as previously described [11 ]. Viabi li ty as determined by trypan 
blue dye exClusion exceeded 80%. 
LC Enrichment 
LC enrichment was achieved by the previously described pan ning 
technique Ill] . Viabil iity after panni ng was generally greater than 75%. 
G05 
Jm nwnofluorescent Staining 
T he binding of antibodies to the epidermal cells was studied by 
indirect immunofluorescence as prev iously described. Five fields wer~ 
randomly selected and at least 100 cells counted. T he result s are 
expressed as a perce nt of OJ<TG-posi tive cell s. ln addi t ion, cells were 
processed on the FACS 111 as previously described [11] . 
Epidermal Cell Cultures 
Viable unseparat.ed epidermal ce lls (1 X 106) or viable LC-enriched 
or -depleted cells (1 x 106 ) were cu ltured fo r 72 h in RPM! 1640 
conta in ing l O% heat- inactivated hu man serum, 100 units/ ml penicil lin, 
100 1-'g/ml gentamicin , 25 mM Hepes buffer, and 2 mM L-glutam ine in 
12 x 75 mm cu lture tubes (Fa lcon Laborato ries) . T he cell -free super-
nata nt was dialyzed against 50 volumes of RPM l 1640, fi lte r sterilized, 
and tested in the ETAF/ IL-1 assay. 
ETA F / IL Assay 
Supernatants were tested fo r ETAF/ IL-1 using the thymocyte pro-
li fera tion assay as previously described [9]. 
Standardizat ion fo r ET A F/ I L-1 Assay 
U nit~ of ETAF were derived using the fo llowing equation as prev i-
ously described [14]: 
reciprocal t ite r of test sample at 30% of maximal cpm of standard 
reciprocal t it.e r of 30% of maximal cpm of standard 
X 100 = uni ts/m l in sample 
T he human epidermoid carcinoma cell line A43l was used to prepare 
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the standard for these assays. This cell line constitutively produces 
ETAF. Biochemical and function al cha racterization has shown that 
A431-derived ETAF is similar to human lL-1 [15]. Supernatant was 
prepared by incubating 1 x 106 A431 cells for 5 days in 75-mm t issue 
cul ture fla sks containing Du lbecco's modified Eagle's medium with 2 
mM glutamine, 100 units/ml pen icillin, 100 mg streptomycin. The cell-
free supernatan t was dialyzed against RPM! 1640 then lilter-sterilized. 
Aliquots were stored at - 2o· c for use as standards in the ETAF assay. 
For eac h assay this standard ETAF preparation was tested in the 
thymocyte assay at increasing dilutions and the filtration curve so 
obtained was arbi t rarily ass igned 100 units of ETAF/m l. 
Blocking St:udies 
To evaluate the relationsh ip between IL-l and these epidermal cell 
facto rs we used ant ibody blocking studies. An affin ity-purified rabbit 
IgG raised aga inst LP was used for these studies. T his antibody has 
been shown to block IL-l. The purification and specificity of this 
antiserum have bee n previously published [1 3,16]. Briefly, purified 
antibody to pyrogen or normal rabbit serum was attached to activated 
Sepharose 4B as previously described [13,15]. 
In. terleullin-2 (1 L-2) Assay 
Epiderma l cell supernata nts from LC-enriched, LC-depleted, or con-
t rol cultures were tested for IL-2 ac tivity by a modification of the 
method of Gillis et al [17] as previously described [9]. 
RESULTS 
Pw:1:[ication of LC by Panning 
The resul ts of 3 experiments are shown in Table I. There 
were approximately 3% via ble OKT6-positive cells (presumably 
LC) in t.he control population . The adherent cell population 
co ntained 84-97% OKT6-positive cells whereas less t han 1% 
of the nonadherent cell s were OKT6-positive . Previous studies 
have s hown that these OKT6-enriched cells demonstrated ul-
trastructural characte ri stics of L C including B irbeck granules 
[ll]. T hese were not seen in t he OKT6-negative cells. In 
addition, previous studies have shown t hat t he enriched popu-
lation was capable of stimulating allogene ic lymphocytes 
whereas t he depleted population did not [11] . 
FA CS Analysis of LC Enrichment by Panning 
Using the panning tech nique, OKT6-enriched or -depleted 
cell s were recovered from a n epidermal cell suspens ion . These 
cell s we re then labeled with R / M-FITC and t heir flu orescence 
intensity was dete rmined using t he FACS III. Integration of 
e ither linear scale or log sca le plots showed 97 % of the cells 
were posit ive for OKT6. 
TABLE J. Epidermal cell production of E1'AF/IL-1 
Source of supern atant Units ETAF/IL-1" 
Adherent (LC-enriched)" 163 ± 26 
Nonad herent (LC-depleted) 138 ± 16 
Unseparated 127 ± 19 
Adherent, nonadherent, or unseparated epidermal cells (1 X 10") 
were cul tured at 37•c for 72 h in RPMI1640 wi th 10% heat-inactivated 
human se rum. The cell -free supernatant was then dialyzed, filter 
sterilized, and tested for ETAF/IL-1 activity. 
"The results are compared to a standard cell line and activity is 
expressed in mean ± SEM units of ETAF/ ml (mean ± SEM of 4 
separate experiments). The human epidermoid carcinoma cell line A431 
was used to prepa re the sta ndard for these assays. This cell line 
constitutively produces ETAF. Biochemical and functional character-
izations have shown that A431-derived ETAF is similar to human IL-
l. Units we re determined using the formula 
reciproca l titer of tes t sample at 30% maximal cpm of standard 
reciprocal tite r of 30% of maximal cpm of standard 
X 100 = units/ml in sample 
1
' The yield or adherent cells was approximately 1% of the ori ginal cell 
suspension. The adherent populations conta ined 84- 97% OKT6-posi-
tive cells. 
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TABLE II. Bloching studies 
Source of 
supern at.a nt. 0 
Adheren t EC (LC-en-
riched) 
Nonadherent EC (LC-de-
pleted) 
Unseparated EC 
ETAF / 1 L- l (unit$/tnl) 1' 
treatrncnt. of su pe rnatant 
Untreated An ti-lgG Anti -LP treated 
170 ± 38 125 ± 27 22 ± 16 
130 ± 43 190 ± 67 22 ± 13 
100 ± 31 150 ± 45 28 ± 7 
"Supern atant from adherent, nonadherent, or unseparated epider-
mal cells (EC) was incubated with anti -LP bound to Sepharose 4B 
normal rabbit serum bound to Sepharose 4B, or without beads over: 
night at 4 · c. The beads were then removed by centrifugation and the 
supernatant was tested for ETAF/ IL-1. 
"Units of ETAF /IL-l expressed as mean ± SEM of 3 separate 
experiments. 
ETAF/!L-1 and IL-2 Activity 
When 1 X 10{;/ml cells were cu ltured for 72 h and the 
supernatant was tested for ET AF /IL-l activity, significant 
activity was found in a ll groups. This activity was compared to 
act ivi ty from our standard ce ll line A431 and resul ts a re ex-
pressed as units ETAF/IL-1/ per ml (Table I). While theoreti-
cally the "conta minating" keratinocytes in the LC-enriched 
fraction could contribute to ETAF/IL-1 activity, this contam-
ination represented at most, 16% of the 1 million cells. When 
t his number of ep idermal cells are placed in culture, no signif-
icant ETAF/lL-1 activity is generated. In addition, no IL- 2 
act ivity was found in any of the groups. 
Bloching Studies 
In order to evaluate t he relationship between IL-l and t hese 
epidermal factors, we used antibody blocking studies. An affin-
ity-purified rabbit IgG raised against monocyte-derived LP was 
used for this purpose. This antibody inhibited both LC and 
keratinocyte ETAF IL-l-like activi ty (Table II). This, there-
fore, implies that a close relations hip (at least antigenically) 
exis ts between LP /ETAF / IL-l and LC-produced IL-l. 
Colwnn Chromatography 
Sephadex G-50 chromatography revealed that both keratin-
ocyte -derived ETAF and LC-derived lL-1 e luted as a major 
peak between 10,000- 20,000 and a minor peak at 43,000. 
DISCUSSION 
We have previously shown t hat human and murine epidermal 
cell cu lture supernatants contain a factor with IL-l-like activ-
ity, termed ETAF [9] . When LC were eliminated from these 
cultures with anti -Ia antiserum plus complement, no decrease 
in ETAF activity was observed [9 ]. In addition, studies with 
human epidermal cells and human cell lines devoid of L C 
produced similar, if not identical, mediators [9,1 5]. This implied 
that LC were not needed for ETAF production, but it did not 
directly address the issue as to whether LC are capable of IL- l 
production . Until recently none of the techniques ava ilable for 
LC purification has been found to be adequate for ac hiev ing 
hi gh-yield purifications within a relatively short period of time. 
Us ing the panning tec hnique as previous ly described [11], we 
obta ined a highly purified LC popula tion. This t hen a llowed u s 
to direct ly address the question of LC production of IL-l. In 
this paper we have shown that normal human LC produce a 
factor that stimulates thymocytes in the standard ETAF/ IL-l 
assay . H.ecent studies have shown t hat LP, the molecule that 
mediates endogenous fever in mammals, is s imilar, if not iden-
tical, to IL-l [16,18]. A heterologous antibody against LP blocks 
IL-l activi ty [13,16]. In addition , we have shown that t his 
a ntibody blocks ETAF activity [15]. Us ing t his antibody 
against the monocyte-derived LP, we were able to inhibit IL- l 
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o r ETAF activity from LC-enriched and -dep leted cell cul tures. 
The resul ts of t his study indicate that within t he epidermis 
t h ere are at least two ce ll popu lations t hat can secrete poten-
tially importa nt so luble immunostimulatory factors . 
Recently, Austryn eta] [1 9) have shown that murine dendri-
t ic ce lls in the absence ofT cell s do not produce IL-l or IL-2. 
In t his report we have shown that a specialized epidermal 
dendrit ic ce ll , the epiderma l LC, produces IL-l. It remains to 
be d etermined whether or not other dendritic ce lls are also 
capable of this function. 
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